![Sharon Longhurst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sharon Longhurst
Director/Board Member at
ELICERA THERAPEUTICS AB
Profile
Dr. Sharon Longhurst is an Independent Director at Elicera Therapeutics AB and an Independent Director at Idogen AB. She is on the Board of Directors at Elicera Therapeutics AB and Idogen AB. Dr. Longhurst was previously employed as a Vice President-Development by Gadeta BV and a Head-Chemistry, Manufacturing & Control by Mendus AB. She received her undergraduate degree from the University of Surrey and a doctorate degree from the University of Warwick.
Sharon Longhurst active positions
| Companies | Position | Start |
|---|---|---|
| ELICERA THERAPEUTICS AB | Director/Board Member | 2023-12-31 |
Idogen AB
 Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Director/Board Member | 2020-05-11 |
Former positions of Sharon Longhurst
| Companies | Position | End |
|---|---|---|
Gadeta BV
 Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Corporate Officer/Principal | 2023-07-31 |
| MENDUS AB | Corporate Officer/Principal | - |
Education of Sharon Longhurst
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Health Technology |
Elicera Therapeutics AB
 Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
- Stock Market
- Insiders
- Sharon Longhurst
